中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2010年
12期
1459-1461
,共3页
王开强%黄爱苹%谢磊%郑金娣%毕好生
王開彊%黃愛蘋%謝磊%鄭金娣%畢好生
왕개강%황애평%사뢰%정금제%필호생
减压术,外科%激光疗法%胶原酶类%椎间盘移位
減壓術,外科%激光療法%膠原酶類%椎間盤移位
감압술,외과%격광요법%효원매류%추간반이위
Decompression,surgical%Laser Therapy%Collagenases%Intervertebral disk displacement
目的 探讨经皮激光汽化减压联合靶点注射胶原酶治疗腰椎间盘突出症的效果.方法 拟行椎间盘松解术的腰椎间盘突出症患者90例,年龄31~52岁,体重58~70 kg,随机分为3组:经皮激光汽化减压组(P组,n=29)、靶点注射胶原酶组(C组,n=31例)和两种方法联合治疗组(PC组,n=30).P组光纤经穿刺针达病变椎间盘后进行激光汽化减压;C组在CT扫描下调整针尖位置,固定于突出物表面后注入胶原酶400~600 U,继续进针刺入突出物后注入200~300 U;PC组在激光汽化减压完成后行靶点注射胶原酶溶解术.于术前、术后7、30、60、90 d采用改良日本骨科学会下腰痛分级(M-JOA)评价疗效.结果 与术前比较,P组和PC组术后各时点M-JOA分级升高,C组术后30、60和90 d升高(P<0.05),术后7 d差异无统计学意义(P>0.05);与术后7d比较,P组术后30 d M-JOA分级降低(P<0.05),术后60、90 d差异无统计学意义(P>0.05),C组和PC组术后30、60和90 dM-JOA分级明显升高(P<0.05);与PC组比较,P组和C组术后各时点M-JOA分级明显降低,近期疗效分级降低.结论 经皮激光汽化减压联合靶点注射胶原酶治疗腰椎间盘突出症疗效稳定,优于两者单独应用.
目的 探討經皮激光汽化減壓聯閤靶點註射膠原酶治療腰椎間盤突齣癥的效果.方法 擬行椎間盤鬆解術的腰椎間盤突齣癥患者90例,年齡31~52歲,體重58~70 kg,隨機分為3組:經皮激光汽化減壓組(P組,n=29)、靶點註射膠原酶組(C組,n=31例)和兩種方法聯閤治療組(PC組,n=30).P組光纖經穿刺針達病變椎間盤後進行激光汽化減壓;C組在CT掃描下調整針尖位置,固定于突齣物錶麵後註入膠原酶400~600 U,繼續進針刺入突齣物後註入200~300 U;PC組在激光汽化減壓完成後行靶點註射膠原酶溶解術.于術前、術後7、30、60、90 d採用改良日本骨科學會下腰痛分級(M-JOA)評價療效.結果 與術前比較,P組和PC組術後各時點M-JOA分級升高,C組術後30、60和90 d升高(P<0.05),術後7 d差異無統計學意義(P>0.05);與術後7d比較,P組術後30 d M-JOA分級降低(P<0.05),術後60、90 d差異無統計學意義(P>0.05),C組和PC組術後30、60和90 dM-JOA分級明顯升高(P<0.05);與PC組比較,P組和C組術後各時點M-JOA分級明顯降低,近期療效分級降低.結論 經皮激光汽化減壓聯閤靶點註射膠原酶治療腰椎間盤突齣癥療效穩定,優于兩者單獨應用.
목적 탐토경피격광기화감압연합파점주사효원매치료요추간반돌출증적효과.방법 의행추간반송해술적요추간반돌출증환자90례,년령31~52세,체중58~70 kg,수궤분위3조:경피격광기화감압조(P조,n=29)、파점주사효원매조(C조,n=31례)화량충방법연합치료조(PC조,n=30).P조광섬경천자침체병변추간반후진행격광기화감압;C조재CT소묘하조정침첨위치,고정우돌출물표면후주입효원매400~600 U,계속진침자입돌출물후주입200~300 U;PC조재격광기화감압완성후행파점주사효원매용해술.우술전、술후7、30、60、90 d채용개량일본골과학회하요통분급(M-JOA)평개료효.결과 여술전비교,P조화PC조술후각시점M-JOA분급승고,C조술후30、60화90 d승고(P<0.05),술후7 d차이무통계학의의(P>0.05);여술후7d비교,P조술후30 d M-JOA분급강저(P<0.05),술후60、90 d차이무통계학의의(P>0.05),C조화PC조술후30、60화90 dM-JOA분급명현승고(P<0.05);여PC조비교,P조화C조술후각시점M-JOA분급명현강저,근기료효분급강저.결론 경피격광기화감압연합파점주사효원매치료요추간반돌출증료효은정,우우량자단독응용.
Objective To investigate the efficacy of percutaneous laser disc decompression(PLDD)combined with injection of collagenase through a target location for treatment of lumbar intervertebral disc protrusion.Methods Ninety patients with lumbar intervertebral disc protrusion scheduled for discolysis,aged 31-52 yr,weighing 58-70 kg,were randomly divided into 3 groups: PLDD group(group P,n = 29),collagenase injection group(group C,n = 31),PLDD combined with injection of collagenase through a target location group(group PC,n = 30).The puncture was performed under the guidance of CT.Group P was treated using PLDD.Group C was treated with collagenase injection.Group PC was treated with injection of collagenase after PLDD was completed.The therapeutic effect was assessed before operation and on day 7,30,60 and 90 after operation using M-JOA score.Results M-JOA grade was significantly higher at the each time point after operation in group P and PC,and on day 30,60 and 90 after operation in group C than that before operation(P < 0.05).M-JOA grade was significantly lower on day 30 after operation in group P,while higher on day 30,60 and 90 after operation in group C and PC than that on day 7 after operation(P < 0.05).M-JOA grade was significantly lower at the each time point after operation in group P and C than in group PC.Conclusion The therapeutic effect of PLDD combined with collagenase injection through a target location is stable for treatment of lumbar intervertebral disc herniation and better than that of PLDD or collagenase injection alone.